A Potent Combo vs. Hepatitis C

A new form of interferon from Roche plus a standard antiviral drug could prove more effective against the often fatal liver disease

A experimental drug made by Roche (RHHBY ) combined with an antiviral medication has proven to be the most effective treatment so far for hepatitis C, according to researchers at Rush-Presbyterian-St. Luke's Medical Center in Chicago. This combination therapy could cut treatment time in half, to 24 weeks from the usual 48, for many patients, the researchers say.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.